December 20, 2016 / 9:19 PM / 7 months ago

BRIEF-Biogen's board approves separation of Bioverativ

1 Min Read

Dec 20 (Reuters) - Biogen Inc :

* Biogen - for every 2 shares of co's common stock held of record on Jan 17 2017, shareholders will receive one share of Bioverativ common stock

* Biogen Inc - its board of directors has approved planned spin-off of its hemophilia business, which will be known as Bioverativ Inc

* Biogen's board of directors approves separation of Bioverativ and declares special dividend distribution of Bioverativ stock Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below